
To determine the extent of informed decision-making and treatment preference of Korean patients receiving zzso zzso 

We assessed 138 patients zzso age: 58 years; zzso zzso with advanced cancer who had received at least one cycle of zzso General demographic information, the extent of information received, patient preferences for zzso chemotherapy and zzso trials were determined using structured patient zzso We investigated the survival threshold for zzso zzso the factors influencing individual preference for chemotherapy and the attitude of patients towards zzso zzso 

Before chemotherapy, zzso of patients were given information about adverse events of treatment, but only zzso were told of alternative zzso There was significant zzso zzso in willingness to accept chemotherapy, as well as a wide range of zzso Patients reporting higher quality of life were more likely to judge treatment as zzso When given the choice for zzso for conventional chemotherapy, zzso agents or supportive care, patients usually refused enrollment into zzso zzso 

zzso quality of life was a significant predictor of stronger preference for zzso In the zzso setting, good zzso communications and consideration of patients' preferences are necessary for making decisions about proper zzso 

